PTK2 and breast carcinoma: GD2 can promote proliferation, invasion, motility, and metastasis of various tumor cell types (27, 28), by inducing phosphorylation through the hepatocyte growth factor (HGF) receptor and c-Met pathway of breast cancer (29) or tyrosine kinase receptors and FAK pathways of osteosarcoma (30).